Regulus Therapeutics and GlaxoSmithKline Establish New Collaboration to …
MarketWatch (press release)
Regulus Therapeutics Inc. today announced the establishment of a new collaboration with GlaxoSmithKline (GSK) to develop and commercialize microRNA …
Market Report — In Play (GSK)
MSN Money
GlaxoSmithKline and Regulus Therapeutics establish new collaboration to develop and commercialize microRNA Therapeutics Targeting miR-122 Co and Regulus …
Regulus, the MicroRNA Child of Isis and Alnylam, Strikes Potential $150M Deal …
Xconomy
Two years have passed since GlaxoSmithKline anointed a startup called Regulus Therapeutics as a leader in the bleeding-edge world of microRNA drugs, …
Related posts:
- Largest microRNA Therapeutics Alliance To Date
- Targeting a Master Regulator of Disease
- RXi Pharmaceuticals and miRagen Therapeutics Announce Formation of Research Collaboration in the Field of microRNA
- A Busy Month in the Business of microRNA
- Alnylam Pharmaceuticals & Regulus Therapeutics in the News
Loading ...